Related Experiment Video
Updated: Apr 21, 2026
10:32
Production and Testing of Antimicrobial Peptides and Their Mimics
Published on: April 10, 2026
345
Antimicrobial γ-AApeptides (WO2013112548): a patent evaluation
Peng Teng1, Haifan Wu, Lili Lin
1University of South Florida, Department of Chemistry , 4202 E. Fowler Ave, Tampa, FL 33620 , USA +1 813 974 9506 ; +1 813 974 3203 ; jianfengcai@usf.edu.
Expert Opinion on Therapeutic Patents
|October 22, 2014
Summary
New γ-AApeptides show strong antimicrobial activity against drug-resistant bacteria. These compounds mimic host-defense peptides, offering a novel strategy to combat antibiotic resistance.
Area of Science:
- Medicinal Chemistry
- Microbiology
- Drug Discovery
Background:
- Antibiotic resistance poses a significant global health threat.
- There is a critical need for novel antimicrobial agents.
- Host-defense peptides (HDPs) offer a natural model for antimicrobial action.
Purpose of the Study:
- To introduce a new class of peptidomimetics, γ-AApeptides.
- To evaluate the antimicrobial activity of these novel compounds.
- To explore their potential as an alternative to conventional antibiotics.
Main Methods:
- Patent application WO2013112548 describes the synthesis and characterization of γ-AApeptides.
- Antimicrobial activity was tested against a range of Gram-positive and Gram-negative bacteria.
- Mechanism of action was investigated, focusing on membrane disruption.
Main Results:
- γ-AApeptides demonstrated potent and broad-spectrum antimicrobial activity.
- Activity was confirmed against clinically relevant, drug-resistant pathogens.
- The compounds function by mimicking the membrane-disrupting mechanism of HDPs.
Conclusions:
- γ-AApeptides represent a promising new class of antimicrobial agents.
- Their ability to overcome antibiotic resistance warrants further investigation.
- These peptidomimetics offer a potential alternative therapeutic strategy.
Related Concept Videos
01:23Antimicrobial Proteins
10.5K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
10.5K
01:23Inhibitors of Gram-positive Cell Wall Synthesis
146
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
146
01:28Antimicrobial Effectiveness
2.3K
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.3K
01:25Inhibitors of Bacterial Protein Synthesis
93
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
93
01:15Antifungal Agents
110
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
110
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
257
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
257